# The Medicines (Products for Human Use) (Fees) Regulations 2016, Regulation 61: Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004


(1) The Medicines for Human Use (Clinical Trials) Regulations 2004 are amended as follows.
(2) In regulations—
(a) 17(2)(b)(ii) (request for authorisation to conduct a clinical trial);
(b) 24(10) (amendments by the sponsor);
(c) 38(3)(b) (application for manufacturing authorisation); and
(d) 44(8) (variation of manufacturing authorisation)
for “Medicines (Products for Human Use) (Fees) Regulations 2013” substitute “ Medicines (Products for Human Use) (Fees) Regulations 2016 ”.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/regulation/61 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/regulation-61
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.